Your session is about to expire
← Back to Search
Smoking Cessation Intervention Bundle for Quitting Smoking (INSPIRE Trial)
N/A
Waitlist Available
Led By Karen M Wilson, MD, MPH
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Families admitted to the inpatient units of Children's Hospital Colorado
Families with children <17 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after patient hospitalization
Awards & highlights
INSPIRE Trial Summary
This trial will test the feasibility of an intervention to reduce tobacco use and dependence among caregivers of hospitalized children.
Eligible Conditions
- Quitting Smoking
- Secondhand Smoke
INSPIRE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowINSPIRE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months after patient hospitalization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after patient hospitalization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Demonstrate whether children whose parents receive the intervention bundle have greater decreases in cotinine levels
Secondary outcome measures
Child exposure prevalence
Child sick visits
Increased parent quit rates
+1 moreINSPIRE Trial Design
2Treatment groups
Experimental Treatment
Group I: Intervention GroupExperimental Treatment1 Intervention
Smoking Cessation Intervention Bundle. The Investigator has developed an intervention that bundles the best evidence for tobacco dependence treatment, including the USPHS guidelines, and evidence from parent-specific interventions, to create a sustainable, transferrable intervention specific to using the inpatient stay to help parents quit smoking and reduce their children's exposure. The intervention bundle includes screening for exposure, assessing readiness to quit, providing at least one brief motivational interviewing session in the hospital, dispensing nicotine replacement therapy if appropriate, providing a smoking cessation/reduction starter kit and arranging for follow up after the child is discharged.
Group II: Control Group: QuitlineExperimental Treatment1 Intervention
Quitline referral. If the family is randomized to the control group, the research team will give the parent a brochure for the QuitLine
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention Bundle
2014
N/A
~600
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,638 Previous Clinical Trials
40,929,219 Total Patients Enrolled
2 Trials studying Quitting Smoking
13,098 Patients Enrolled for Quitting Smoking
University of Colorado, DenverLead Sponsor
1,730 Previous Clinical Trials
2,142,897 Total Patients Enrolled
Karen M Wilson, MD, MPHPrincipal InvestigatorUniversity of Colorado, Denver
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger